A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency
- 1 December 2009
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 50 (6) , 1348-1358.e3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyThe Lancet Neurology, 2009
- Chronic cerebrospinal venous insufficiency in patients with multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2008
- The unsolved puzzle of multiple sclerosis and venous functionJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Interferon-β treatment for relapsing multiple sclerosisExpert Opinion on Biological Therapy, 2008
- Seven-Tesla Magnetic Resonance ImagingArchives of Neurology, 2008
- Raised venous pressure as a factor in multiple sclerosisMedical Hypotheses, 2008
- Primary Budd-Chiari syndrome: Outcome of endovascular management for suprahepatic venous obstructionJournal of Vascular Surgery, 2006
- Physiology of cerebral venous blood flow: from experimental data in animals to normal function in humansBrain Research Reviews, 2004
- The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessmentMultiple Sclerosis Journal, 1999
- Rating neurologic impairment in multiple sclerosisNeurology, 1983